Recent Quotes (30 days)

You have no recent quotes
chg | %

Uscom Ltd  

(Public, ASX:UCM)   Watch this stock  
Find more results for ASX: UCM
0.000 (0.00%)
Dec 14 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range     -
52 week 0.13 - 0.28
Open     -
Vol / Avg. 0.00/51,760.00
Mkt cap 16.91M
P/E     -
Div/yield     -
EPS -0.02
Shares 112.24M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin -60.28% -51.68%
Operating margin -58.19% -50.34%
EBITD margin - -42.17%
Return on average assets -38.54% -35.32%
Return on average equity -45.37% -41.32%
Employees 11 -
CDP Score - -


SE 1 L 7, 10 Loftus St
+61-2-92474144 (Phone)
+61-2-92478157 (Fax)

Website links


USCOM Limited is engaged in the development, design, manufacture and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The Company manages a network of distribution partners across the world for the sale of its equipment to hospitals and other medical care locations. Its geographic segments include Australia, Asia, the Americas, Europe and Mid East and Africa, and Other Regions. The Company has approximately three practice suites of devices in the field of cardiac, vascular and pulmonary monitoring, including the USCOM 1A, which is an advanced hemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment; USCOM BP+, which is a supra systolic oscillometric Central Blood Pressure monitor that measures blood pressure and blood pressure waveforms only previously available using cardiac catheterization, and the Uscom SpiroSonic spirometers, which is a digital pulmonary testing device.

Officers and directors

Robert Allan Phillips Chief Executive Officer, Chief Scientist, Executive Chairman of the Board
Nick Schicht General Manager
Steve Haken Global Sales Manager
Denise Pater Distribution and Sales Manager
Brett Thomas Crowley Company Secretary
Chao Xian He Director
Christian Robert Bernecker Non-Executive Director
Sheena Gae Jack Non-Executive Director